Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Pharmaron Beijing Co Ltd’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 18 Oct 2023 | Rxilient Biotech Raises USD30 Million in Venture Financing | Venture Financing |
Legend Capital Co Ltd
Pharmaron Beijing Co Ltd |
Rxilient Biotech Pte Ltd
|
| 18 Oct 2023 | Pharmaron, China Medical System, Kanglianda and Legend Fund to Form Joint Venture in Singapore | Partnership |
Rxilient Biotech Pte Ltd
|
China Medical System Holdings Ltd
Legend Fund LLC
Pharmaron (Hong Kong) International Ltd
Kanglianda
|
| 09 Mar 2023 | Immuron Ltd Enters Phase II Clinical Trial Agreement with Pharmaron Beijing Co Ltd for IMM-124E (GDCT0481502) | Contract Service Agreement |
Immuron Ltd
|
Pharmaron Beijing Co Ltd |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer